Business·Industry

“First Production of Robot Actuators… Aiming to Contribute to Company-Wide Earnings by 2030”—LGELECTRONICS Conference Call

JAEMIN SONG
2026-07-30 17:28:05
[Edaily Reporter JAEMIN SONG ] “In the first half of the year, we established an actuator pilot line at our Changwon plant and are currently verifying mass-production feasibility and stabilizing quality through the production of initial batches. In the second half of the year, we plan to introduce automated equipment and make additional infrastructure investments, while simultaneously pursuing joint development and collaboration with startups and major robotics companies in Korea, Europe, and North America. We plan to expand our product portfolio and production capacity to develop this into a business that will make a meaningful contribution to the company’s overall business performance by around 2030.”

…LGELECTRONICS Q2 2026 Conference Call

LGELECTRONICS Twin Towers at the company’s headquarters in Yeouido, Yeongdeungpo-gu, Seoul. (Photo: Yonhap News)

Economy

Corporation

IT·Science

Economy

"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]

A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
2026-08-08 11:01:04

Corporation

Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”

“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
2026-08-08 08:16:01

IT·Science

SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]

(Graphic: Generative AI) During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
2026-08-08 08:31:03